Product Information

LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.0289 per EA under NDC 76282044690. Its NADAC has been published 359 times since Oct 9, 2019.

FDA first approved this application on May 23, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB

Lisinopril and Hydrochlorothiazide Tablets
$0.0289per EA

Strength

12.5; 10 mg/1; mg/1

NDC

76282044690

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA204058

FDA Approved

5/23/2017

TE Code

AB

On Market Since

5/1/2019

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB has been published 359 times since Oct 9, 2019, and over the history we have for it it has declined 22.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0289 per EA
All-time high$0.0407 (Aug 11, 2021)
All-time low$0.0241 (Nov 20, 2024)
52-week high$0.0307
52-week low$0.0284
Median price$0.0335
Average price$0.0337
Largest weekly change-25.4% (Nov 20, 2024)
Weeks tracked359
Tracking sinceOct 9, 2019

Price History

1W

+0.5%

1M

+0.5%

3M

+0.7%

6M

-1.8%

1Y

-4.4%

3Y

-12.1%

5Y

-27.0%

All

-22.2%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB, manufactured by Exelan Pharmaceuticals Inc., is $0.0289 per EA (NDC 76282044690), effective Aug 19, 2026.

How has the price of LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB changed over time?

Over the history we have for it, the NADAC for LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB has declined 22.2%. It has been tracked across 359 weekly CMS publications since Oct 9, 2019.

What are the highest and lowest recorded NADAC prices for LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?

Since Oct 9, 2019, the NADAC for LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB has ranged from a low of $0.0241 (Nov 20, 2024) to a high of $0.0407 (Aug 11, 2021), with a median of $0.0335 per EA.

Are there cheaper alternatives to LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?

LISINOPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB (NDC 76282044690) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.